Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].

Saved in:
Bibliographic Details
Title: Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
Authors: Poh, Xuan Ying1 (AUTHOR), Lee, I. Russel1 (AUTHOR), Lim, Clarissa1 (AUTHOR), Teo, Jefanie1 (AUTHOR), Rao, Suma1,2 (AUTHOR), Chia, Po Ying1,2,3 (AUTHOR), Ong, Sean W. X.1,2 (AUTHOR), Lee, Tau Hong1,2 (AUTHOR), Lin, Ray J. H.1,2 (AUTHOR), Ng, Lisa F. P.4,5 (AUTHOR), Ren, Ee Chee6 (AUTHOR), Lin, Raymond T. P.7 (AUTHOR), Wang, Lin-Fa8 (AUTHOR), Renia, Laurent3,4 (AUTHOR), Lye, David Chien1,2,3,5 (AUTHOR), Young, Barnaby E.1,2,3 (AUTHOR) barnaby_young@ncid.sg
Source: Trials. 6/16/2022, Vol. 23 Issue 1, p1-13. 13p. 3 Charts.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17456215
DOI:10.1186/s13063-022-06345-2